Moderna Moving to Late-Stage Trial on COVID-Flu Combo Vaccine

October 5, 2023

(Axios) – Moderna said Wednesday it plans to begin a late-stage trial on a combination COVID-flu vaccine later this year in adults 50 years old and above, with an eye toward regulatory approval in 2025. Why it matters: A combined shot could simplify immunizations while simultaneously fighting two respiratory diseases that require repeated vaccinations. (Read More)